相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Combined Accelerator Mass Spectrometry-Positron Emission Tomography Human Microdose Study with C-14- and C-11-Labelled Verapamil
Claudia C. Wagner et al.
CLINICAL PHARMACOKINETICS (2011)
Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands
David R. J. Owen et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans
E. A. Rabiner et al.
MOLECULAR PSYCHIATRY (2011)
Towards molecular imaging of multiple sclerosis
David R. J. Owen et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
In Vivo Binding of Antipsychotics to D3 and D2 Receptors: A PET Study in Baboons with [11C]-(+)-PHNO
Ragy R. Girgis et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Immuno-Positron Emission Tomography: Shedding Light on Clinical Antibody Therapy
Guus A. M. S. van Dongen et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2010)
Tumor Survivin Is Downregulated by the Antisense Oligonucleotide LY2181308: A Proof-of-Concept, First-in-Human Dose Study
Denis C. Talbot et al.
CLINICAL CANCER RESEARCH (2010)
Adaptive-Optimal Design in PET Occupancy Studies
S. Zamuner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications
Bernd J. Pichler et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Evaluation of 11C-GSK189254 as a Novel Radioligand for the H3 Receptor in Humans Using PET
Sharon Ashworth et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O. Rinne et al.
LANCET NEUROLOGY (2010)
A New Model for Prediction of Drug Distribution in Tumor and Normal Tissues: Pharmacokinetics of Temozolomide in Glioma Patients
Lula Rosso et al.
CANCER RESEARCH (2009)
Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
O. D. Howes et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
The potential of PET/MR for brain imaging
Wolf-Dieter Heiss
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Advances in the molecular imaging of multiple sclerosis
Paul M. Matthews et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2009)
A Biomathematical Modeling Approach to Central Nervous System Radioligand Discovery and Development
Qi Guo et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Clinical Applications of Positron Emission Tomography (PET) Imaging in Medicine: Oncology, Brain Diseases and Cardiology
Sean L. Kitson et al.
CURRENT RADIOPHARMACEUTICALS (2009)
Synthesis of C-11, F-18, O-15, and N-13 Radiolabels for Positron Emission Tomography
Philip W. Miller et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Consensus nomenclature for in vivo imaging of reversibly binding radioligands
Robert B. Innis et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Degradative transport of cationic amphiphilic drugs across phospholipid bilayers
Magdalena Baciu et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2006)
Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain
SG Summerfield et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Multidrug resistance: Retrospect and prospects in anti-cancer drug treatment
Ricardo Perez-Tomas
CURRENT MEDICINAL CHEMISTRY (2006)
Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases
W Löscher et al.
PROGRESS IN NEUROBIOLOGY (2005)
Predicting P-glycoprotein substrates by a quantitative structure-activity relationship model
VK Gombar et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
PET studies on P-glycoprotein function in the blood-brain barrier: How it affects uptake and binding of drugs within the CNS
PH Elsinga et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Positron emission tomography microdosing:: a new concept with application in tracer and early clinical drug development
M Bergström et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs)
AD Van den Abbeele et al.
EUROPEAN JOURNAL OF CANCER (2002)
Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers
M Slifstein et al.
NUCLEAR MEDICINE AND BIOLOGY (2001)
Relationship between dopamine D2 occupancy, clinical response, and side effects:: A double-blind PET study of first-episode schizophrenia
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
A new, convenient method for the preparation of 4-[F-18]fluorobenzyl halides
R Iwata et al.
APPLIED RADIATION AND ISOTOPES (2000)
分享论文
